Latest News
FDA Approved Bristol Myers Squibb’s Breyanzi as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Details >FDA Granted Accelerated Approval of BeiGene's BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!